OptimizeRx Corp·4

Nov 7, 5:51 PM ET

D'Silva Andrew J. 4

4 · OptimizeRx Corp · Filed Nov 7, 2025

Insider Transaction Report

Form 4
Period: 2025-10-01
D'Silva Andrew J.
Chief Business Officer
Transactions
  • Tax Payment

    Common Stock

    2025-10-01$18.98/sh414$7,85847,100 total
  • Tax Payment

    Common Stock

    2025-10-03$18.75/sh794$14,88846,306 total
Footnotes (1)
  • [F1]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

Documents

1 file
  • 4
    wk-form4_1762555864.xmlPrimary

    FORM 4